| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/03/2005 | US20050026244 Recombinant narbonolide polyketide synthase |
| 02/03/2005 | US20050026236 PDE 10 cell-based assay and sequences |
| 02/03/2005 | US20050026233 Using bioassay for loss-of-function mutations in protein kinase (LKB1) as diagnostic tool in detection of cell proliferative disorders; AMP-activated protein kinase (AMPK) and treatment of diabetic, cardiovascular and dietetic disorders |
| 02/03/2005 | US20050026232 Monoclonal antibody which preferentially binds leukocyte common antigen-related molecule phosphatase (LAR) for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 02/03/2005 | US20050026226 Serum Paraoxonase |
| 02/03/2005 | US20050026214 Method of identifying glycosyl transferase binding compounds |
| 02/03/2005 | US20050026213 Mammalian Galanin receptors |
| 02/03/2005 | US20050026211 Compositions and methods relating to lung specific genes |
| 02/03/2005 | US20050026210 Expression vector comprising antisense nucleotide sequence associated with suppression of polynucleotides coding enzymatic polypeptide associated with the conversion of 1-propenylsulfenic acid to thiopropanal S-oxide; transgenic plants and food processing |
| 02/03/2005 | US20050026208 Generating region of template polynucleotide containing target sequence via rolling circle or polymerase chain replication; probe generation |
| 02/03/2005 | US20050026207 CACNA1G polynucleotide, polypeptide and methods of use therefor |
| 02/03/2005 | US20050026201 Using cells with aberrant apoptosis as diagnostic tools in identifying agents for treatment and prevention of cell proliferative disorders |
| 02/03/2005 | US20050026194 Using overexpression of relaxin-3 and somatostatin and angiotensin-like peptide receptor (SALPR) as diagnostic indicator of cell proliferative disorders |
| 02/03/2005 | US20050026193 Using nuclease protection to identify preferential nucleotide sequences |
| 02/03/2005 | US20050026186 Method for evaluating an inclination of a subject to lung cancer |
| 02/03/2005 | US20050026182 Human CDNAS and proteins and uses thereof |
| 02/03/2005 | US20050026181 Bio bar-code |
| 02/03/2005 | US20050026180 Direct multiplex characterization of genomic DNA |
| 02/03/2005 | US20050026177 Preparing pharmaceutical grade plasmids for use as gene transfer tools in genetic engineering |
| 02/03/2005 | US20050026176 DNA probe design device and information processing method for DNA probe design |
| 02/03/2005 | US20050026175 Devices and methods for isolating RNA |
| 02/03/2005 | US20050026172 Identifying concensus sequences associated with g protein coupled receptors and using these to generate RNA sequences which interfefre with the expression and of membrane protein receptors; post-transcriptional silencing of polynucleotides |
| 02/03/2005 | US20050026169 Using presence of single nucleotide polymorphism in apopoliprotein gene sequences as diagnostic indicator of cardiovascular disorders |
| 02/03/2005 | US20050026163 Method for sequencing nucleic acids by observing the uptake of nucleotides modified with bulky groups |
| 02/03/2005 | US20050026162 Compositions and methods for the modification of gene expression |
| 02/03/2005 | US20050026160 Compositions comprising alternating 2'-modified nucleosides for use in gene modulation |
| 02/03/2005 | US20050026159 Devices and methods for isolating RNA |
| 02/03/2005 | US20050026157 Enzymatic fusion protein comprising cleavage and nuclear localization domain for use gene targeting tool in gene therapeutics |
| 02/03/2005 | US20050026153 Devices and methods for isolating RNA |
| 02/03/2005 | US20050026149 Expression vector comprising chimeric nucleotide comprising nuclear, choloroplast and/or mitochondrial localization signals for use as tools in transfer of heterologous genes into preferential genomes |
| 02/03/2005 | US20050026146 Method for the simultaneous dissection in specific positions of filiform organic molecular chains, in particular dna |
| 02/03/2005 | US20050026143 Synthesis of biologically active compounds in cells |
| 02/03/2005 | US20050026139 Generating transgenic cell comprising expression vector coding apotosis inducing factor for use in treatment of cell proliferative and viral disorders |
| 02/03/2005 | US20050026137 Expression vector comprising nucleotide sequences coding multimeric nuclear anchoring-protein for use as tool in transfer, expression and propagation of heterologous gene sequences |
| 02/03/2005 | US20050025821 Lipid-comprising drug delivery complexes and methods for their production |
| 02/03/2005 | US20050025820 Method and system for systemic delivery of growth arresting, lipid-derived bioactive compounds |
| 02/03/2005 | US20050025815 Protonated/acidified nucleic acids are effective as bactericidal and/or bacteriostatic agents |
| 02/03/2005 | US20050025775 Contacting a sample with an isolated monoclonal antibody that binds to a substantially-pure coagulase-negative Staphylococcus epidermidis capsular polyssocharide adhesin antigen that binds to polymeric material, wherein said adhesin antigen inhibits binding to polymeric material |
| 02/03/2005 | US20050025772 Monoclonal antibody 108-394 binds to shared epitope of protein p24 and protein p26; diagnostic kits; conjugate of antibody attached to a signal generating compound; sensitivity |
| 02/03/2005 | US20050025771 Antitumor agents comprising a targeting portion and an immune response triggering portion |
| 02/03/2005 | US20050025766 Inducing cytolysis of undesirable cells or immunostimulation by administering a targeting agent for the PML protein or an agent inducing overexpression of the PML protein |
| 02/03/2005 | US20050025760 Pemphigus monoclonal antibody |
| 02/03/2005 | US20050025753 Methods for production of non-disease causing hemoglobin by ex vivo oligonucleotide gene editing of human stem/progenitor cells |
| 02/03/2005 | US20050025751 Increased or reduced expression of tumor necrosis factors or interleukins; antiinflammatory agents; autoimmune diseases |
| 02/03/2005 | US20050025750 Sperm-induced cellular activation |
| 02/03/2005 | US20050025749 Grafting heart tissue; closure of heart defect |
| 02/03/2005 | US20050025747 Containing a priming and boosting composition, each with a non-replicating viral vector, with at least one of them being derived from a fowlpox virus; malaria, tuberculosis |
| 02/03/2005 | US20050025746 Delivering an adeno-associated virus vector comprising a nucleotide sequence encoding glutamic acid decarboxylase to cells in specific areas of the brain; Parkinson's Disease, Alzheimer's Disease, Amyloid Lateral Sclerosis, and epilepsy |
| 02/03/2005 | DE10328669A1 Plasmidfreier Klon des E. coli Stammes DSM 6601 Plasmid-free clone of E. coli strain DSM 6601 |
| 02/03/2005 | DE10012670B4 Mikrodissektion von Fluoreszenz in situ hybridisierten chromosomalen Material (FISH-MD) Microdissection of fluorescence in situ hybridized chromosomal material (FISH-MD) |
| 02/03/2005 | CA2850891A1 Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cells |
| 02/03/2005 | CA2536644A1 Antibodies and uses thereof |
| 02/03/2005 | CA2533691A1 Thioaptamers enable discovery of physiological pathways and new therapeutic strategies |
| 02/03/2005 | CA2533479A1 Peptide protein translation inhibitor and the use thereof for protein translation control |
| 02/03/2005 | CA2533315A1 Rat model of diabetic nephropathy |
| 02/03/2005 | CA2532939A1 Plant cell cycle genes and methods of use |
| 02/03/2005 | CA2532809A1 Plant centromere compositions |
| 02/03/2005 | CA2532591A1 Industrial method for producing rna and system for carrying out said method |
| 02/03/2005 | CA2532370A1 Polypeptides for inducing a protective immune response against staphylococcus aureus |
| 02/03/2005 | CA2532084A1 Methods of treatment and diagnosis using modulators of virus-induced cellular gene sequences |
| 02/03/2005 | CA2531559A1 Adenoviral e1a/e1b complementing cell line |
| 02/03/2005 | CA2531493A1 Device and method to facilitate directed delivery and electroporation |
| 02/03/2005 | CA2531492A1 Compositions for purifying and crystallizing molecules of interest |
| 02/03/2005 | CA2531105A1 Method and compositions for detection and enumeration of genetic variations |
| 02/03/2005 | CA2530284A1 Il-17 a/f heterologous polypeptides and therapeutic uses thereof |
| 02/03/2005 | CA2530178A1 Methods for generating or increasing revenues from crops |
| 02/03/2005 | CA2530168A1 Method of judging risk for drug-induced granulocytopenia |
| 02/03/2005 | CA2530085A1 Compositions and methods for the production of betaine lipids |
| 02/03/2005 | CA2529369A1 Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cells |
| 02/03/2005 | CA2527557A1 Genes encoding carotenoid compounds |
| 02/03/2005 | CA2527369A1 Subgroup b adenoviral vectors for treating disease |
| 02/03/2005 | CA2526814A1 Non-glycosylated human alpha-fetoprotein, methods of production, and uses thereof |
| 02/03/2005 | CA2502923A1 Polynucleotide sequence variants |
| 02/02/2005 | EP1503321A2 Protein design automation for protein libraries |
| 02/02/2005 | EP1502962A2 Methods for assessing and treating cancer |
| 02/02/2005 | EP1502960A1 Method of detecting rheumatoid arthritis by detecting overexpression of wnt |
| 02/02/2005 | EP1502959A1 A procedure for the creation and use of DNA-recognition element libraries in vivo in relation to gene expression |
| 02/02/2005 | EP1502958A1 New detection format for hot start real time polymerase chain reaction |
| 02/02/2005 | EP1502955A1 Methods for the production of stably transformed, fertile gramineae employing agrobacterium-mediated transformation of isolated gramineae zygotes |
| 02/02/2005 | EP1502954A1 Utilisation of constructs comprising recombination sequence motifes for enhancing gene expression in moss |
| 02/02/2005 | EP1502953A1 Chemically-inducible promoters for the expression of proteins in plants |
| 02/02/2005 | EP1502952A2 Process for the production of protein products in Aspergillus oryzae and a promoter for use in Aspergillus |
| 02/02/2005 | EP1502951A1 Devices and methods for isolating RNA |
| 02/02/2005 | EP1502950A2 Method for purifying chemically modified RNA |
| 02/02/2005 | EP1502948A1 Ammonia-oxidizing bacteria |
| 02/02/2005 | EP1502921A1 Recombinant mutated human factor VIII (FVIII) with improved stability |
| 02/02/2005 | EP1502920A2 Cell surface molecule mediating cell adhesion and signal transmission |
| 02/02/2005 | EP1502603A1 DRUG CONTAINING ANTIBODY COMPOSITION APPROPRIATE FOR PATIENT SUFFERING FROM Fc gamma RIIIa POLYMORPHISM |
| 02/02/2005 | EP1502602A2 Methods for therapeutic vaccination |
| 02/02/2005 | EP1502599A1 Active antiangiogenic therapy |
| 02/02/2005 | EP1502222A2 A distributed system for epigenetic based prediction of complex phenotypes |
| 02/02/2005 | EP1502115A2 Method of identifying ligands for nuclear receptors |
| 02/02/2005 | EP1502114A1 THE METHOD FOR MEASURING THE AMOUNT OF $g(b)iG-H3 PROTEIN AND DIAGNOSTIC KIT USING THE SAME |
| 02/02/2005 | EP1502112A2 Use of specific t2r taste receptors to identify compounds that block bitter taste |
| 02/02/2005 | EP1502109A2 Compositions and methods relating to endothelial cell signaling using the protease activated receptor (par1) |
| 02/02/2005 | EP1502105A2 Methods for designing oligo-probes with high hybridization efficiency and high antisense activity |
| 02/02/2005 | EP1501950A2 Methods and compositions for dna manipulation |
| 02/02/2005 | EP1501949A2 Ssh based methods for identifying and isolating unique nucleic acid sequences |
| 02/02/2005 | EP1501948A1 A dna enzyme to inhibit plasminogen activator inhibitor-1 |
| 02/02/2005 | EP1501947A2 Method of creating a library of bacterial clones with varying levels of gene expression |